Link Between MMR Vaccination Rates and Healthcare Budget Reductions in Italy

Overview of Measles and the MMR Vaccine

An Italian study investigated the correlation between decreasing MMR vaccination rates and the recent measles outbreak, particularly in the context of healthcare budget cuts. Measles is a highly contagious viral disease that manifests through symptoms such as high fever, sore throat, runny nose, and a rash. Serious complications, including pneumonia and encephalitis, can arise, potentially resulting in long-term disabilities or fatalities. The MMR vaccine is known for its effectiveness in preventing measles, with current health guidelines recommending that children receive the first dose between 12 to 15 months and a second dose between 4 to 6 years of age. Achieving a vaccination rate of approximately 95% is essential for establishing “herd immunity,” which protects vulnerable, unimmunized individuals from outbreaks.

Measles Increase in Deprived Areas of Italy

In recent years, several countries have witnessed a decline in MMR vaccination rates, leading to measles outbreaks. The rise of anti-vaccination groups, which propagate unfounded claims regarding the safety of the MMR vaccine and its alleged links to autism, is often cited as a significant factor in this decline. Interestingly, in Italy, while anti-vaccination sentiments are more prevalent in wealthier regions, the rise in measles cases has been predominantly observed in less affluent areas, suggesting that additional factors may be at play.

Research on Healthcare Budget Impact

Researchers from Bocconi University in Milan conducted a study to examine whether the decrease in MMR vaccination rates and the subsequent measles outbreak could be attributed to reductions in healthcare budgets. Their findings were published in the European Journal of Public Health. The researchers analyzed data from the Italian National Institute of Health regarding MMR vaccination rates for children at 24 months of age across 19 Italian regions from 2000 to 2014. They also reviewed per-capita annual public health spending for the same timeframe, adjusted for inflation.

Findings on MMR Coverage and Spending

The study revealed a consistent increase in public health expenditure, averaging about 3.5% annually until 2009, after which it witnessed a decline of approximately 2% from 2010 to 2014. The most significant budget cuts were observed in the economically disadvantaged Southern regions, where some areas experienced reductions exceeding 10%. MMR vaccination rates initially increased from roughly 74% in 2000 to about 90% in 2012, but subsequently fell to around 85% by 2014. Regional disparities in vaccination coverage were noted; for example, Lazio experienced a 5% decrease in public health spending, correlating with a more than 3% drop in MMR coverage. Conversely, Sardinia, despite its historical deprivation, saw a slight increase in public health funding, which helped maintain steady MMR coverage.

Using statistical modeling, the researchers estimated that every 1% decrease in per-capita public health expenditure was linked to a 0.5 percentage point decline in MMR vaccination coverage.

Conclusions and Government Response

The researchers concluded that the reduction in public health funding is associated with declining MMR vaccination rates, contributing to the recent measles outbreak. In response, the Italian government is working to reverse this trend by increasing healthcare budgets and enforcing mandatory vaccinations for children. These initiatives are aimed at boosting MMR coverage and enhancing measles prevention efforts.

References

Toffolutti V, McKee M, Melegaro A, et al. Austerity, measles, and mandatory vaccination: cross-regional analysis of vaccination in Italy 2000-14. European Journal of Public Health DOI: 10.1093/eurpub/cky178.
EurekAlert. Healthcare cuts “strongly linked” to the resurgence of measles. 12 Sept 2018. https://www.eurekalert.org/pub_releases/2018-09/bu-hc091218.php